Evaluation of the U.S. Marshals Service’s Pharmaceutical Drug Costs and Procurement Process
- NARA ID
- evaluation-us-marshals-services-pharmaceutical-drug-costs-and-procurement-process
- Source
- oig-doj
- Collection
- DOJ OIG — U.S. Marshals Service
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Inspection / Evaluation
- Released
- 2022-12-21
- Slug
- doj-oig-evaluation-us-marshals-services-pharmaceutical-drug-costs-and-procurement-process
- Indexed
- 2026-04-27 05:02:06
More from DOJ OIG — U.S. Marshals Service
- Audit of the United States Marshals Service's Information Security Program Pursuant to the Federal Information Security Modernization Act of 2014 Fiscal Year 2017
- Interim Report on the Department of Justice's Handling of Known or Suspected Terrorists Admitted Into the Federal Witness Security Program
- United States Marshals Service Annual Financial Statements Fiscal Year 2011
- Review of the United States Marshals Service’s Accounting of Drug Control Funding Fiscal Year 2025
- Audit of the United States Marshals Service's Information Security Program Pursuant to the Federal Information Security Modernization Act of 2014, Fiscal Year 2020
- Audit of the U.S. Marshals Service Judicial Security Activities
Browse all 48 documents in DOJ OIG — U.S. Marshals Service →
About the DOJ OIG — U.S. Marshals Service collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning United States Marshals Service.